AbClon Wins U.S. Patent for CD30 CAR-T Therapy Developed with UPenn

China approves world's first CAR-T cell therapy for solid tumors: CARsgen's satri-cel for advanced gastric cancer

CARsgen Therapeutics has received approval from China's NMPA for satricabtagene autoleucel (satri-cel; CT041), the world's first CAR-T cell

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers

Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from

OHSU advances massive leap in medical science with cellular therapies

Phase I CARLYSLE study: CAR T-cell therapy obe-cel shows favorable safety and clinical benefit in severe refractory lupus

This article reports initial results from the phase I CARLYSLE study evaluating obecabtagene autoleucel (obe-cel), a CD19-targeting CAR T-ce

OHSU logra un gran avance en la ciencia médica con las terapias celulares

Resetting autoimmune disease with CAR cell therapies